Dietary folate does not significantly affect the intestinal microbiome, inflammation or tumorigenesis in azoxymethane-dextran sodium sulphate-treated mice

British Journal of Nutrition

Volumn 109, Issue 4, 2013, Pages 630-638

  MacFarlane, Amanda J ^a,b,c   Behan, Nathalie A ^a   Matias, Fernando M G ^a   Green, Judy ^a   Caldwell, Don ^a   Brooks, Stephen P J ^a,c  

^a Health Canada and World Health Organization Collaborating Center for Standardization and Evaluation of Biologicals   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c CARLETON UNIVERSITY   (Canada)

Author keywords

Colon cancer; Folate; Homocysteine; Inflammatory bowel disease; Microflora

Indexed keywords

AZOXYMETHANE; DEXTRAN SULFATE; FOLIC ACID; HOMOCYSTEINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CELL AGGREGATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET SUPPLEMENTATION; DIET THERAPY; DIETARY INTAKE; HISTOPATHOLOGY; INTESTINE FLORA; MALE; MAST CELL; MICROBIOME; MORBIDITY; MOUSE; NONHUMAN; PREVALENCE; PROTEIN BLOOD LEVEL; TUMOR DIFFERENTIATION; TUMOR GROWTH; ULCERATIVE COLITIS;

ANIMALS; AZOXYMETHANE; BIOLOGICAL MARKERS; COLITIS, ULCERATIVE; COLON; COLONIC NEOPLASMS; DEXTRAN SULFATE; DEXTRANS; DIET; DISEASE PROGRESSION; FOLIC ACID; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; MICROBIOTA; NEOPLASMS; RNA, RIBOSOMAL, 16S; SULFATES;

EID: 84885761817     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114512001857     Document Type: Article

References (55)

1. Bernstein CN, Wajda A, Svenson LW, et al. (2006) The epidemiology of inflammatory bowel disease in Canada: a population-based study. Am J Gastroenterol 101, 1559-1568. (Pubitemid 43980630)
2. MacFarlane AJ & Stover PJ (2007) Convergence of genetic, nutritional and inflammatory factors in gastrointestinal cancers. Nutr Rev 65, S157-S166.
3. Shanahan F & Bernstein CN (2009) The evolving epidemiology of inflammatory bowel disease. Curr Opin Gastroenterol 25, 301-305.
4. Bernstein CN, Kraut A, Blanchard JF, et al. (2001) The relationship between inflammatory bowel disease and socioeconomic variables. Am J Gastroenterol 96, 2117-2125. (Pubitemid 32660907)
5. Kappelman MD, Rifas-Shiman SL, Porter CQ, et al. (2008) Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults. Gastroenterology 135, 1907-1913.
6. Itzkowitz SH & Yio X (2004) Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol 287, G7-17. (Pubitemid 38802113)
7. Eaden JA, Abrams KR & Mayberry JF (2001) The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 48, 526-535. (Pubitemid 32234798)
8. Ekbom A, Helmick C, Zack M, et al. (1990) Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 323, 1228-1233. (Pubitemid 20366527)
9. Rutter M, Saunders B, Wilkinson K, et al. (2004) Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 126, 451-459. (Pubitemid 38182302)
10. Fox JT & Stover PJ (2008) Folate-mediated one-carbon metabolism. Vitam Horm 79, 1-44.
11. Jiang Y, Zhao J, Jiang T, et al. (2010) Genetic polymorphism of methylenetetrahydrofolate reductase G1793A, hyperhomocysteinemia, and folate deficiency correlate with ulcerative colitis in central China. J Gastroenterol Hepatol 25, 1157-1161.
12. Chowers Y, Sela BA, Holland R, et al. (2000) Increased levels of homocysteine in patients with Crohn's disease are related to folate levels. Am J Gastroenterol 95, 3498-3502.
13. Lashner BA (1993) Red blood cell folate is associated with the development of dysplasia and cancer in ulcerative colitis. J Cancer Res Clin Oncol 119, 549-554. (Pubitemid 23180046)
14. Lashner BA, Provencher KS, Seidner DL, et al. (1997) The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis. Gastroenterology 112, 29-32. (Pubitemid 27008982)
15. Biasco G, Zannoni U, Paganelli GM, et al. (1997) Folic acid supplementation and cell kinetics of rectal mucosa in patients with ulcerative colitis. Cancer Epidemiol Biomarkers Prev 6, 469-471. (Pubitemid 27270553)
16. Mahmud N, Molloy A, McPartlin J, et al. (1999) Increased prevalence of methylenetetrahydrofolate reductase C677T variant in patients with inflammatory bowel disease, and its clinical implications. Gut 45, 389-394. (Pubitemid 29400715)
17. Chen M, Peyrin-Biroulet L, Xia B, et al. (2008) Methionine synthase A2756G polymorphism may predict ulcerative colitis and methylenetetrahydrofolate reductase C677T pancolitis, in Central China. BMC Med Genet 9, 78.
18. Zintzaras E (2010) Genetic variants of homocysteine/folate metabolism pathway and risk of inflammatory bowel disease: a synopsis and meta-analysis of genetic association studies. Biomarkers 15, 69-79.
19. Oussalah A, Gueant JL & Peyrin-Biroulet L (2011) Meta-analysis: hyperhomocysteinaemia in inflammatory bowel diseases. Aliment Pharmacol Ther 34, 1173-1184.
20. Halsted CH, Gandhi G & Tamura T (1981) Sulfasalazine inhibits the absorption of folates in ulcerative colitis. N Engl J Med 305, 1513-1517.
21. Danese S, Sgambato A, Papa A, et al. (2005) Homocysteine triggers mucosal microvascular activation in inflammatory bowel disease. Am J Gastroenterol 100, 886-895. (Pubitemid 40592384)
22. Phelip JM, Ducros V, Faucheron JL, et al. (2008) Association of hyperhomocysteinemia and folate deficiency with colon tumors in patients with inflammatory bowel disease. Inflamm Bowel Dis 14, 242-248. (Pubitemid 351288046)
23. Papa A, De Stefano V, Danese S, et al. (2001) Hyperhomocysteinemia and prevalence of polymorphisms of homocysteine metabolism-related enzymes in patients with inflammatory bowel disease. Am J Gastroenterol 96, 2677-2682.
24. Drzewoski J, Gasiorowska A, Malecka-Panas E, et al. (2006) Plasma total homocysteine in the active stage of ulcerative colitis. J Gastroenterol Hepatol 21, 739-743.
25. Poddar R, Sivasubramanian N, DiBello PM, et al. (2001) Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells: implications for vascular disease. Circulation 103, 2717-2723. (Pubitemid 32538788)
26. Robert K, Nehme J, Bourdon E, et al. (2005) Cystathionine beta synthase deficiency promotes oxidative stress, fibrosis, and steatosis in mice liver. Gastroenterology 128, 1405-1415. (Pubitemid 40712189)
27. Peyrin-Biroulet L, Rodriguez-Gueant RM, Chamaillard M, et al. (2007) Vascular and cellular stress in inflammatory bowel disease: revisiting the role of homocysteine. Am J Gastroenterol 102, 1108-1115. (Pubitemid 46698241)
28. Neufert C, Becker C & Neurath MF (2007) An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression. Nat Protoc 2, 1998-2004. (Pubitemid 47308138)
29. Boivin GP, Washington K, Yang K, et al. (2003) Pathology of mouse models of intestinal cancer: consensus report and recommendations. Gastroenterology 124, 762-777. (Pubitemid 36268493)
30. Whiteley LO, Hudson L Jr & Pretlow TP (1996) Aberrant crypt foci in the colonic mucosa of rats treated with a genotoxic and nongenotoxic colon carcinogen. Toxicol Pathol 24, 681-689. (Pubitemid 27029912)
31. Riddell RH, Goldman H, Ransohoff DF, et al. (1983) Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 14, 931-968.
32. Herbig K, Chiang EP, Lee LR, et al. (2002) Cytoplasmic serine hydroxymethyltransferase mediates competition between folate-dependent deoxyribonucleotide and S-adenosylmethionine biosyntheses. J Biol Chem 277, 38381-38389. (Pubitemid 35154694)
33. Abnous K, Brooks SP, Kwan J, et al. (2009) Diets enriched in oat bran or wheat bran temporally and differentially alter the composition of the fecal community of rats. J Nutr 139, 2024-2031.
34. Brooks SP, Kheradpir E, McAllister M, et al. (2009) In-feed administered sub-therapeutic chlortetracycline alters community composition and structure but not the abundance of community resistance determinants in the fecal flora of the rat. Anaerobe 15, 145-154.
35. Schloss PD, Westcott SL, Ryabin T, et al. (2009) Introducing mothur: open-source, platform-independent, communitysupported software for describing and comparing microbial communities. Appl Environ Microbiol 75, 7537-7541.
36. Tamura K, Dudley J, Nei M, et al. (2007) MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24, 1596-1599. (Pubitemid 47236692)
37. Schloss PD, Larget BR & Handelsman J (2004) Integration of microbial ecology and statistics: a test to compare gene libraries. Appl Environ Microbiol 70, 5485-5492. (Pubitemid 39279626)
38. Jones RT & Martin AP (2006) Testing for differentiation of microbial communities using phylogenetic methods: accounting for uncertainty of phylogenetic inference and character state mapping. Microb Ecol 52, 408-417. (Pubitemid 44899533)
39. Lozupone C, Hamady M & Knight R (2006) UniFrac-an online tool for comparing microbial community diversity in a phylogenetic context. BMC Bioinformatics 7, 371.
40. Schloss PD (2008) Evaluating different approaches that test whether microbial communities have the same structure. ISME J 2, 265-275. (Pubitemid 351334275)
41. Lozupone CA, Hamady M, Kelley ST, et al. (2007) Quantitative and qualitative beta diversity measures lead to different insights into factors that structure microbial communities. Appl Environ Microbiol 73, 1576-1585. (Pubitemid 46417883)
42. Beals EW (1984) Bray-Curtis ordination: an effective strategy for analysis of multivariate ecological data. Adv Ecol Res 14, 1-55.
43. Stackebrandt E & Goebel BM (1994) Taxonomic note: a place for DNA-DNA reassociation and 16S rRNA sequence analysis in the present species definition in bacteriology. Int J Syst Bacteriol 44, 846-849. (Pubitemid 24315169)
44. Chapkin RS, Kamen BA, Callaway ES, et al. (2009) Use of a novel genetic mouse model to investigate the role of folate in colitis-associated colon cancer. J Nutr Biochem 20, 649-655.
45. Pretlow TP & Pretlow TG (2005) Mutant KRAS in aberrant crypt foci (ACF): initiation of colorectal cancer? Biochim Biophys Acta 1756, 83-96. (Pubitemid 41781960)
46. Cole BF, Baron JA, Sandler RS, et al. (2007) Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA 297, 2351-2359. (Pubitemid 46883748)
47. Wu K, Platz EA, Willett WC, et al. (2009) A randomized trial on folic acid supplementation and risk of recurrent colorectal adenoma. Am J Clin Nutr 90, 1623-1631.
48. Figueiredo JC, Mott LA, Giovannucci E, et al. (2011) Folic acid and prevention of colorectal adenomas: a combined analysis of randomized clinical trials. Int J Cancer 129, 192-203.
49. Carrier J, Medline A, Sohn KJ, et al. (2003) Effects of dietary folate on ulcerative colitis-associated colorectal carcinogenesis in the interleukin 2-and beta(2)-microglobulin-deficient mice. Cancer Epidemiol Biomarkers Prev 12, 1262-1267. (Pubitemid 37499455)
50. Mondot S, Kang S, Furet JP, et al. (2011) Highlighting new phylogenetic specificities of Crohn's disease microbiota. Inflamm Bowel Dis 17, 185-192.
51. Willing BP, Dicksved J, Halfvarson J, et al. (2010) A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology 139, 1844-1854.
52. Lyra A, Rinttila T, Nikkila J, et al. (2009) Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification. World J Gastroenterol 15, 5936-5945.
53. Lupp C, Robertson ML, Wickham ME, et al. (2007) Hostmediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2, 119-129. (Pubitemid 47209521)
54. Kassinen A, Krogius-Kurikka L, Makivuokko H, et al. (2007) The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 133, 24-33. (Pubitemid 47031125)
55. Nagalingam NA, Kao JY & Young VB (2011) Microbial ecology of the murine gut associated with the development of dextran sodium sulfate-induced colitis. Inflamm Bowel Dis 17, 917-926.